Skip to main content

Table 1 Prognostic genes regulated by DNA methylation identified in AML by genome-wide, large sample studies

From: Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia

Reference

DNA methylation detection methods

AML group

Prognostic genes regulated by DNA methylation

Figueroa et al. [16]

HELP

344 Newly diagnosed AML

BLR1 (CXCR5), BTBD3, E2F1, FAM110A, FAM30A, GALNT5, KIAA1305, LCK, LMCD1, PRMT7, SLC7A6OS, SMG6, SRR, USP50, VWF, ZFP161

Li et al. [9]

ERRBS

138 Paried AML (diagnosis and relapse)

CCDC85C, CHL1, ELAVL2, FAM115A, FAM196A, GPR146, GPR6, HELZ2, ID4, IL2RA, KCNG3, LOC254559, LOC284801, NPAS2, PCDHAC2, PROB1, SHISA6, SLC18A3, SOCS2, TRIM67, ZFP42

Marcucci et al. [50]

MethylCap-seq

134 CN-AML (355 CN-AML validated)

AATK, ACAP3, ADCK2, ADCY6, AGPAT9, AHCY, ALOX15B, ANXA6, APBB1, APOD, AQP11, ARHGAP27, AXL, BRF1, C15orf62, C17orf77, C8orf51, CABLES1, CARD11, CD34 a, CHMP7, CISH, CLDN15, CLEC3B, DDIT4, DHCR24, DHRS12, EGFL7, ETS1, EVC, F2RL1 a, FAM92A1 a, FCHO1, FKBP4, FLVCR1, FLVCR1-AS1, FZD6, GAL3ST3, GCNT2, GIT1, GPR56, H1F0, HCN2, HIVEP3, IQSEC1, KCNK6, KDM2B, KLHL3, KNCN, LOC646627, MDFI, ME3, MEOX1, MIR126, MIR155HG a, MVD, NAV1, NBL1, NLRP1, PLK3, PMM1, PRKCZ, PRKG2, RAB36, RGS3, RHOC a, RHPN1, SCARF1, SCRN1 a, SH3TC1, SPRY1, SRC, TBL2, TCEA3, TENC1, UBXN6, VWA8 a, WDR16, WDR86, WRAP53, ZNF623, ZNF70

  1. aSeven genes (CD34, RHOC, SCRN1, F2RL1, FAM92A1, MIR155HG, and VWA8) had not only DNA methylation regions (DMRs) but also expression levels that were associated with outcome